Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CVR Energy
CVI
$3.54B
| $644K | ﹤0.01% |
51,957
+6,060
| +13% | +$103K |
|
|
CMA
3002
CALL
DELISTED
Comerica
CMA
| $643K | ﹤0.01% |
16,800
-10,200
| -38% | -$392K |
|
|
EXAS
3003
CALL
DELISTED
Exact Sciences
EXAS
| $642K | ﹤0.01% |
6,300
| – | – |
|
3004
Goosehead Insurance
GSHD
$2.35B
| $642K | ﹤0.01% |
7,432
-3,545
| -32% | -$323K |
|
3005
PUT
APA Corp
APA
$14.2B
| $639K | ﹤0.01% |
67,500
+19,500
| +41% | +$267K |
|
|
SRDX
3006
DELISTED
Surmodics
SRDX
| $639K | ﹤0.01% |
16,407
+4,224
| +35% | +$186K |
|
3007
CALL
Thomson Reuters
TRI
$44.9B
| $638K | ﹤0.01% |
7,593
| – | – |
|
3008
Theravance Biopharma
TBPH
$881M
| $637K | ﹤0.01% |
43,120
-28,124
| -39% | -$527K |
|
|
ZYXI
3009
DELISTED
Zynex
ZYXI
| $637K | ﹤0.01% |
40,174
+14,468
| +56% | +$244K |
|
|
PRSU
3010
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $637K | ﹤0.01% |
30,574
-7,839
| -20% | -$147K |
|
|
SIX
3011
DELISTED
Six Flags Entertainment Corp.
SIX
| $637K | ﹤0.01% |
31,290
+2,075
| +7% | +$42.7K |
|
|
KRTX
3012
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $637K | ﹤0.01% |
8,247
-1,048
| -11% | -$89.3K |
|
3013
Ascendis Pharma A/S
ASND
$16.3B
| $636K | ﹤0.01% |
4,121
+138
| +3% | +$19.8K |
|
3014
Dorian LPG
LPG
$2.03B
| $636K | ﹤0.01% |
79,315
+23,200
| +41% | +$192K |
|
3015
Santander
BSBR
$43.2B
| $635K | ﹤0.01% |
134,173
-35,626
| -21% | -$184K |
|
3016
International Bancshares
IBOC
$4.56B
| $635K | ﹤0.01% |
24,412
-6,599
| -21% | -$202K |
|
3017
PUT
Infosys
INFY
$49B
| $634K | ﹤0.01% |
45,900
| – | – |
|
3018
CALL
LivePerson
LPSN
$35.2M
| $634K | ﹤0.01% |
813
-74
| -8% | -$55.6K |
|
|
HTZ
3019
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $634K | ﹤0.01% |
571,600
-81,800
| -13% | -$118K |
|
3020
Element Solutions
ESI
$9.46B
| $633K | ﹤0.01% |
60,253
-43,529
| -42% | -$477K |
|
|
RRD
3021
DELISTED
RR Donnelley & Sons Co.
RRD
| $633K | ﹤0.01% |
433,487
-50,622
| -10% | -$64.3K |
|
3022
Kadant
KAI
$3.95B
| $632K | ﹤0.01% |
5,768
-922
| -14% | -$105K |
|
3023
CALL
ProShares Ultra S&P500
SSO
$8.47B
| $632K | ﹤0.01% |
34,400
-68,800
| -67% | -$1.24M |
|
3024
Universal Electronics
UEIC
$67.9M
| $632K | ﹤0.01% |
16,735
+4,260
| +34% | +$185K |
|
3025
Evolent Health
EVH
$529M
| $631K | ﹤0.01% |
50,866
-9,475
| -16% | -$111K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.